Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Channel Therapeutics Corp (CHRO)

Channel Therapeutics Corp (CHRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Roche Holding AG (RHHVF) Gets a Buy from DZ BANK AG

DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Roche Holding AG today. The company’s shares closed yesterday at $351.28.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

In a report released today, Matthew Weston from UBS maintained a Buy rating on Roche Holding AG, with a price target of CHF314.00. The company’s shares closed last Friday at $357.00.Elevate Your Investing...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
J.P. Morgan Sticks to Their Sell Rating for Roche Holding AG (RHHVF)

In a report released today, Richard Vosser from J.P. Morgan maintained a Sell rating on Roche Holding AG, with a price target of CHF230.00. The company’s shares closed last Friday at $357.00.Elevate...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
Roche Holding AG (RHHVF) Receives a Hold from Barclays

In a report released today, Yihan Li from Barclays maintained a Hold rating on Roche Holding AG, with a price target of CHF275.00. The company’s shares closed yesterday at $362.85.Elevate Your Investing...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
J.P. Morgan Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG today and set a price target of CHF230.00. The company’s shares opened today at $360.22.Elevate Your Investing Strategy:...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)

Goldman Sachs analyst Rajan Sharma maintained a Sell rating on Roche Holding AG today and set a price target of CHF248.00. The company’s shares closed last Friday at $360.15.Elevate Your Investing Strategy:...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
HSBC upgrades Roche Holding AG (RHHVF) to a Buy

In a report released yesterday, Rajesh Kumar from HSBC upgraded Roche Holding AG to a Buy, with a price target of CHF320.00. The company’s shares closed yesterday at $353.22.Elevate Your Investing Strategy:...

RHHVF : 466.5080 (+0.32%)
RHHBY : 57.4775 (+1.14%)
CHRO : 1.3500 (+7.14%)
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement

LGND : 181.18 (-3.12%)
PTHS : 22.40 (-0.47%)
CHRO : 1.3500 (+7.14%)
Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement

CHRO : 1.3500 (+7.14%)
Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

CHRO : 1.3500 (+7.14%)

Barchart Exclusives

Dear CoreWeave Stock Fans, Mark Your Calendars for February 26
CoreWeave is set to post its fourth-quarter results later this month as investors watch closely. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar